Low Risk Bonds in USD
Smart Portfolio
================================================== 🛡️ eToro’s @FED-RatePlus Smart Portfolio is now open for investments! 💵📈 ================================================== In periods of macro uncertainty, many investors prefer to stay defensive — keeping capital productive without taking unnecessary risk. Short-duration fixed income strategies are designed precisely for these environments, offering income potential while limiting exposure to interest-rate volatility. The new @FED-RatePlus Smart Portfolio focuses on short-duration USD fixed income instruments, helping reduce sensitivity to rate changes while maintaining high liquidity. By emphasizing short maturities and strong credit quality, the portfolio aims to provide a conservative yield alternative for investors looking to temporarily park capital rather than fully allocate to risk assets. This Smart Portfolio is built around a diversified basket of USD-denominated accumulative UCITS ETFs, combining U.S. sovereign bonds with investment-grade corporate credit. The allocation typically targets ~60% government bonds and ~40% investment-grade credit, with flexibility to adjust as market conditions evolve — all while maintaining a low-risk profile. The portfolio invests across multiple ETF providers including $ERNA.L (iShares USD Ultrashort Bond UCITS ETF), $SMTC.L (Amundi Smart Overnight Return UCITS ETF USD Hedged Acc), $ZPR1.DE (SS SPDR Bloomberg 1-3 Month T-Bill UCITS ETF), $IB01.L (iShares $ Treasury Bond 0-1yr UCITS ETF), $VDST.L (Vanguard US Treasury 0-1 Year Bond UCITS ETF), $BB3M.L (JPMorgan Betabuilders US Treasury Bond 0-3 Months UCITS ETF), and $XT0D.L (Xtrackers US Treasuries Ultrashort Bond UCITS ETF), offering structured, liquid, and diversified access to short-duration fixed income in a single solution. ================================================== 💰 Minimum investment: $500 🌐 Add the @FED-RatePlus Smart Portfolio to your watchlist today ================================================== Past performance is not indicative of future results.